Similar articles

• Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.

  Meyer P, Bohnen NI, Barkan AL, Shapiro B. Meyer P, et al. Nuklearmedizin. 1999;38(2):66-7. Nuklearmedizin. 1999. PMID: 10100234
• Receptor imaging in the diagnosis and treatment of pituitary tumors.

  Colao A, Lastoria S, Lombardi G. Colao A, et al. J Endocrinol Invest. 1999 Oct;22(9):736-7. doi: 10.1007/BF03343636. J Endocrinol Invest. 1999. PMID: 10595838 No abstract available.
• [Imaging of metastases from thyroid carcinomas using 111In-pentetreotide scintigraphy].

  Görges R, Eissner D, Kahaly G, Voges E, Kersjes W, Bockisch A. Görges R, et al. Nuklearmedizin. 1995 Aug;34(4):165-9. Nuklearmedizin. 1995. PMID: 7675648 German.
• [Role of somatostatin analogs in the treatment of neuroendocrine tumours].

  Cuccurullo V, Cascini GL, Rambaldi PF, Mansi L. Cuccurullo V, et al. Minerva Endocrinol. 2001 Sep;26(3):135-43. Minerva Endocrinol. 2001. PMID: 11753236 Review. Italian.
• [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].

  Banzo J, Abós MD, Prats E, García F, Razola P. Banzo J, et al. Rev Esp Med Nucl. 2000 Jun;19(3):225-41. Rev Esp Med Nucl. 2000. PMID: 11062088 Review. Spanish. No abstract available.